Serum Fluorescence of Advanced Glycation End Products: A Potential Screening Tool to Distinguish Between Diabetic Patients with and without Microvascular Complications
Introduction: Enhanced formation and accumulation of Fluorescent Advanced Glycation End products (F-AGEs) in diabetes mellitus have been linked to increased risk of developing the associated vascular complications. Aim: To evaluate the potential of serum fluorescence levels of F-AGEs as screeni...
Main Authors: | Sadaf Ali, Nivedita L Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2020-11-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/14191/45484_CE[Ra1]_F(SL)_PF1(AKA_KM)_PN(SL).pdf |
Similar Items
-
The role of phenofibrate in the treatment of microvascular complications of type 2 diabetes mellitus
by: Larisa Viktorovna Koshel', et al.
Published: (2009-12-01) -
Preventing microvascular complications in type 1 diabetes mellitus
by: Vijay Viswanathan
Published: (2015-01-01) -
The relationship between microvascular complications and depression in patients with type 2 diabetes mellitus who use insulin
by: Mehmet Ali Eren, et al.
Published: (2013-03-01) -
Frequency of Microvascular Complications in the Early Phase of Diabetes Mellitus Type 2 with Albuminuria
by: Ismana Surkovic, et al.
Published: (2021-01-01) -
Vitamin D levels and microvascular complications in type 2 diabetes
by: Sarita Bajaj, et al.
Published: (2014-01-01)